Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 1

1(50.0%)

Phase 4

1(50.0%)

2Total

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT06734988Recruiting

EXTEND ARDS-J Esophageal Pressure Study

Role: lead

NCT04408703Completed

PRognOstiC valuE of rEd Density in Ulcerative Colitis

Role: collaborator

NCT02280837Completed

Is Glucagon-like Peptide-1 Insufficiency a Residual Risk in Coronary Artery Disease?

Role: lead

NCT01760967Phase 4Completed

Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial

Role: collaborator

NCT01700907Phase 1Completed

Optimization of Desflurane in Elderly Patients

Role: lead

All 5 trials loaded